Apr. 22 at 1:49 AM
$IMMX quietly building the entire commercialization + regulatory stack at once 👀
Everyone saw the Senior Medical Writer role… but zoom out:
Last week:
• Director, Medical Affairs
• Sr Manager / AD, Commercial Data Analytics
Now:
• Senior Medical Writer – Regulatory
That’s not random hiring. That’s phase transition hiring.
👉 Medical Writer = preparing IND/NDA/BLA docs (FDA-facing)
👉 Medical Affairs Director = KOL engagement, data dissemination, launch readiness
👉 Commercial Analytics = market sizing, patient targeting, revenue modeling
You don’t hire:
* Medical Affairs (pre-launch function)
* Commercial analytics (revenue infrastructure)
* AND regulatory writing (submission engine)
…unless you’re moving from clinical → regulatory → commercial
This is what pre-approval buildout actually looks like behind the scenes.
No PR. No hype. Just execution.
⸻
Translation:
They’re not acting like a Phase 1 biotech anymore.
They’re staffing like a company that expects to file, position, and potentially launch.
🎯 NEXICART-2 enrollment done
🎯 Regulatory writing ramping
🎯 Commercial + medical affairs coming online
Connect the dots.
Cheers
